Profile Picture
  • All
  • Web
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost recent
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA approves pancreatic cancer drug made available in Omaha

Digest more
 · 3h · on MSN
Revolution Medicines wins FDA approval for pancreatic cancer pill. What it means for the stock.
Daraxonrasib, the pill touted by a former member of Congress and cancer patient as a ‘miracle drug,’ has been granted approval in patients with pancreatic adenocarcinoma.

Continue reading

 · 5h
FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer
 · 7h · on MSN
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
1hon MSN

Nvidia, Meta, Revolution Medicines, Abercrombie, Intuit, Salesforce, Moderna, and more stocks that explain today’s market

Meta Platforms agrees to pay $18 billion to settle a lawsuit over its social media practices.
21y

Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.

Detailed price information for Revolution Medicines Inc (RVMD-Q) from The Globe and Mail including charting and trades.
pharmaphorum
4h

Revolution's ASCO showstopper gets FDA greenlight

Revolution Medicines' Rasonque (daraxonrasib), the RAS inhibitor that received a standing ovation at ASCO for its doubling of overall survival in patients with metastatic pancreatic ductal ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
  • Privacy
  • Terms